The criminal justice system's goal of eliminating drug use among criminal defendants is driven by the twin goals of reducing criminal behavior and guaranteeing the appearance of defendants at criminal hearings. Data were gathered among a cohort of 6,103 males arrested in New York City to investigate relationships among drug use at arrest, other defendant characteristics, and pretrial failure to appear (FTA) as one key measure of pretrial misconduct. Arrestees were interviewed and submitted to a urine test for drug consumption. The findings suggested that mass drug screening of arrestees may not be a cost-effective way to identify defendants at high risk for pretrial misconduct. Policy and program issues are considered in terms of pretrial release and supervision, resources, the technology of drug testing, and constitutional and due process issues. 5 tables, 6 notes, and 41 references
Downloads
Similar Publications
- ortho-Methylfentanyl Proliferating Across North America As Newest Synthetic Opioid Identified in Fatal Drug Overdoses
- Victimization and Resistance Strategies Among Female Offenders
- Exploring How Prison-Based Drug Rehabilitation Programming Shapes Racial Disparities in Substance Use Disorder Recovery